blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2054081

EP2054081 - JC VIRUS VACCINE [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  29.06.2012
Database last updated on 07.10.2024
Most recent event   Tooltip29.06.2012Refusal of applicationpublished on 01.08.2012  [2012/31]
Applicant(s)For all designated states
Baylor Research Institute
Suite 125, 3434 Live Oak Street
Dallas, TX 75204 / US
[2009/19]
Inventor(s)01 / BOLAND, Clement, Richard
2214 Allen Street
Dallas, TX 75204 / US
 [2009/19]
Representative(s)SONN Patentanwälte GmbH & Co KG
Riemergasse 14
1010 Wien / AT
[N/P]
Former [2009/19]Sonn & Partner Patentanwälte
Riemergasse 14
1010 Wien / AT
Application number, filing date07872285.731.08.2007
[2009/19]
WO2007US77397
Priority number, dateUS20060841393P31.08.2006         Original published format: US 841393 P
[2009/19]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008091398
Date:31.07.2008
Language:EN
[2008/31]
Type: A2 Application without search report 
No.:EP2054081
Date:06.05.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2008 takes the place of the publication of the European patent application.
[2009/19]
Search report(s)International search report - published on:US30.10.2008
(Supplementary) European search report - dispatched on:EP18.06.2010
ClassificationIPC:A61K39/12
[2009/19]
CPC:
A61K39/12 (EP,US); A61P31/20 (EP); A61P37/04 (EP);
A61P43/00 (EP); A61K2039/5256 (EP,US); A61K2039/542 (EP,US);
C12N2710/22034 (EP,US); C12N2710/24143 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/19]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:IMPFSTOFF GEGEN DEN JC-VIRUS[2009/19]
English:JC VIRUS VACCINE[2009/19]
French:VACCIN CONTRE LE VIRUS JC[2009/19]
Entry into regional phase12.01.2009National basic fee paid 
12.01.2009Search fee paid 
12.01.2009Designation fee(s) paid 
12.01.2009Examination fee paid 
Examination procedure12.01.2009Examination requested  [2009/19]
22.02.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
21.04.2011Amendment by applicant (claims and/or description)
23.05.2011Despatch of a communication from the examining division (Time limit: M02)
25.07.2011Reply to a communication from the examining division
16.01.2012Application refused, date of legal effect [2012/31]
16.01.2012Date of oral proceedings
19.03.2012Despatch of communication that the application is refused, reason: substantive examination [2012/31]
19.03.2012Minutes of oral proceedings despatched
Divisional application(s)EP12159167.1  / EP2465532
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.05.2011
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
21.04.2011Request for further processing filed
21.04.2011Full payment received (date of receipt of payment)
Request granted
11.05.2011Decision despatched
Fees paidRenewal fee
14.08.2009Renewal fee patent year 03
27.08.2010Renewal fee patent year 04
05.08.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI]  - ALTSCHULER E L, "Viral Inoculation for Prophylaxis of polyoma virus associated diseases", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US LNKD- DOI:10.1054/MEHY.2000.1280, vol. 56, no. 1, ISSN 0306-9877, (20010101), pages 24 - 25, (20001208), XP008102922 [X] 1,17 * the whole document * [I] 2-16

DOI:   http://dx.doi.org/10.1054/mehy.2000.1280
 [A]  - REST STUDY TEAM, "Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine", NEW ENGLAND JOURNAL OF MEDICINE, (200601), vol. 354, no. 1, ISSN 0028-4793, pages 23 - 33, XP002585724 [A] 1-17 * the whole document *
 [A]  - BOLAND C RICHARD, "Evidence for an association between JC virus and colorectal neoplasia", CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, (200412), vol. 13, no. 12, ISSN 1055-9965, pages 2285 - 2286, XP002585725 [A] 1-17 * the whole document *
 [L]  - N. Meyers, "JC Virus", (2010), Baylor research Institute, URL: http://www.baylorhealth.edu/Research/TechTransfer/IPLists/po_jcvirusbhcs1027.htm, (20100604), XP002585726 [L] * the whole document *
International search[Y]US5750110  (PRIEELS JOHN PAUL [BE], et al);
 [Y]US6238859  (LUEKE WOLFGANG [DE], et al);
 [Y]  - ALTSCHULER L., "Viral Inoculation for Prophylaxis of polyoma virus associated diseases", MEDICAL HYPOTHESES, (2001), vol. 56, no. 1, pages 24 - 25, XP008102922

DOI:   http://dx.doi.org/10.1054/mehy.2000.1280
 [Y]  - MURDIN ET AL., "Poliovirus Hybrids Expressing Neutralization Epitopes from Variable Domains I and IV of the Major Outer Membrane Protein of Chlamydia trachomatis Elicit Broadly Cross-Reactive C. trachomatis-Neutralizing Antibodies", INFECTION AND IMMUNITY, (1995), vol. 63, no. 3, pages 1116 - 1121, XP008102787
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.